Little Green Pharma (ASX:LGP) Retained Earnings

: A$-26.26 Mil (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Little Green Pharma's retained earnings for the quarter that ended in Sep. 2023 was A$-26.26 Mil.

Little Green Pharma's quarterly retained earnings declined from Dec. 2021 (A$-2.78 Mil) to Mar. 2023 (A$-24.09 Mil) and declined from Mar. 2023 (A$-24.09 Mil) to Sep. 2023 (A$-26.26 Mil).

Little Green Pharma's annual retained earnings increased from Jun. 2020 (A$-18.81 Mil) to Jun. 2021 (A$5.80 Mil) but then declined from Jun. 2021 (A$5.80 Mil) to Mar. 2023 (A$-24.09 Mil).

Little Green Pharma Retained Earnings Historical Data

The historical data trend for Little Green Pharma's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Little Green Pharma Annual Data

Trend

Jun19

Jun20

Jun21

Mar23

Retained Earnings

-15.00

-18.81

5.80

-24.09

Little Green Pharma Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Mar23	Sep23
Retained Earnings	Get a 7-Day Free Trial			-18.32	5.80	-2.78	-24.09	-26.26

Little Green Pharma Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Little Green Pharma (ASX:LGP) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Little Green Pharma (ASX:LGP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Little Green Pharma Ltd (ASX:LGP) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

66 Kings Park Road, Level 2, Suite 2, West Perth, Perth, WA, AUS, 6005

Website

https://www.littlegreenpharma.com

Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). The company offers LGP-branded medicinal cannabis oil products in the Australian and European markets.

Little Green Pharma (ASX:LGP) Headlines

No Headlines